Holen Sie sich die Stockscreener-App
3.50
2.19%
0.075
Handel nachbörslich:
3.43
-0.07
-2.00%
Genprex Inc Aktie (GNPX) Neueste Nachrichten
Andelyn Biosciences Secures Manufacturing Role in Genprex Diabetes Gene Therapy Program - TipRanks
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program - PR Newswire
Genprex Inc. (GNPX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Genprex signs CDMO deal to scale up diabetes gene therapy manufacturing - Minichart
Form 8K Genprex Inc For: 18 August By Investing.com - Investing.com Nigeria
Genprex partners with CDMO for diabetes gene therapy manufacturing By Investing.com - Investing.com Nigeria
Genprex (GNPX) Partners with CDMO to Advance Diabetes Gene Thera - GuruFocus
Genprex partners with CDMO for diabetes gene therapy manufacturing - Investing.com
GenprexTransfers Diabetes Product Manufact - Moomoo
Genprex advances AAV diabetes gene therapy manufacturing - TipRanks
Genpre announces CDMO partnership to scale AAV diabetes gene therapy toward cGMP clinical supply - TradingView
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy - PR Newswire
GNPX Q1 2026 Earnings: Clinical-Stage Biotech Posts $0.64 Per Share Loss as Pipeline Development ContinuesGuidance Update - vinanet.vn
Genprex, Inc. Q2 2026: Net loss $(4.45M), EPS $(9.40) — 10-Q Summary - TradingView
Genprex (NASDAQ: GNPX) details Q2 loss and cash runway into 2027 - Stock Titan
Genprex Inc (GNPX) Debt 2025 - Stock Titan
Genprex (GNPX) Surges 5% on Renewed Biotech Interest — Key Levels to WatchShort Setup Alerts - vinanet.vn
Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer (PR Newswire) - Aktiellt
Genprex Inc (STU:2DE1) Stock Earnings Transcripts - GuruFocus
Genprex Inc (STU:2DE1) Stock Price & 30 Year Financial Data - GuruFocus
Genprex Inc (GNPX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Genprex Inc (GNPX) Stock News Today - TradingKey
Genprex (GNPX) Q1 2026 Earnings: Net Loss of $0.64 Per Share Highlights Pre-Revenue Clinical Development Stage - dars.gov.et
Genprex Regains Nasdaq Compliance, Listing Status Secured - The Globe and Mail
Genprex, Inc. (NASDAQ: GNPX) regains Nasdaq minimum bid compliance - Stock Titan
Genprex partners with Roche Diagnostics on biomarker validation for NSCLC - Yahoo Finance
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies - Morningstar
Genprex, Roche Partner on NSCLC Biomarker Validation - TipRanks
Genprex Shares Rise After Collaboration With Roche Diagnostics - finance.yahoo.com
GNPX Stock Draws Trader Focus After Wild Price Swing - StocksToTrade
Why is Genprex stock sliding today? By Investing.com - Investing.com Canada
Weekly Recap: Nasdaq exception and Roche Diagnostics TROP2 validation - TradingView
Genprex stock rises on Roche Diagnostics collaboration By Investing.com - Investing.com India
Genprex partners with Roche on lung cancer biomarker studies - Investing.com Nigeria
Genprex partners with Roche on lung cancer biomarker studies By Investing.com - Investing.com Canada
Genprex Granted Nasdaq Listing Exception Amid Compliance Push - The Globe and Mail
Genprex Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Genprex Inc (GNPX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Genprex Inc (GNPX) Institutional Confidence - TradingKey
Genprex Inc (GNPX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Genprex Inc (GNPX) Earnings Date & Reports & Earnings News - TradingKey
Genprex Inc (GNPX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Genprex Inc (GNPX) Valuation: PE, PB & Fair Value Analysis - TradingKey
GNPX|Genprex Inc|Price:3.950|Chg%:-0.040 - TradingKey
TradingKey - TradingKey
GNPX|Genprex Inc|Price:7.735|Chg%:-0.075 - TradingKey
GNPX|Genprex Inc|Price:4.700|Chg%:+0.230 - TradingKey
Genprex Inc Revenue Breakdown – LSE:0A8I - TradingView
AMD Stock Price Today, Analysis, News and Trading Ideas - Stocktwits
GNPX Q1 2026 Earnings: Pre-Revenue Biotech Reports EPS of -$0.64, Shares Slide 11%Weak Earnings Momentum - vinanet.vn
Gross margin % of Genprex Inc – MUN:2DE1 - TradingView
CapEx per share of Genprex Inc – MUN:2DE1 - TradingView
Dilution adjustment of Genprex Inc – MUN:2DE1 - TradingView
Total debt of Genprex Inc – MUN:2DE1 - TradingView
Total revenue of Genprex Inc – MUN:2DE1 - TradingView
Genprex (GNPX) Virtual Road Show with CEO Rodney Varner Transcript - GuruFocus
Genprex Inc C-Suite Interview with Noble Capital Markets Transcript - GuruFocus
Genprex (GNPX) Channelchek C-Suite Series, CEO Rodney Varner interview with Noble's Dr. Ahu Demir Transcript - GuruFocus
Genprex Inc Global One Media Interview Transcript - GuruFocus
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):